News

Eli Lilly: A Textbook Insider Buying Play

Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...
FiercePharma18d

Mounjaro measures up to Trulicity in Eli Lilly cardio trial

Lilly has presented results from a phase 3 trial in which Mounjaro measures up head-to-head against the company’s GLP-1 Trulicity in reducing cardiovascular risks in patients with Type 2 ...

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry

Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...

Cost of Mounjaro set to almost triple but people may still be able to get discounts

Mounjaro manufacturer Eli Lilly said it was raising the price by up to 170% which could hit people paying privately for the ...
Straight Arrow News on MSN4d

Eli Lilly accused of bribing doctors to prescribe Mounjaro and other drugs

Texas Attorney General Ken Paxton filed a lawsuit against Eli Lilly, accusing the drug maker of bribing doctors to prescribe ...

Lilly’s Mounjaro Exhibits Heart Benefits In Type 2 Diabetes Landmark Trial

Eli Lilly and Company (NYSE:LLY) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Eli Lilly and Company ...